DNA Vaccines Market By Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

DNA Vaccines Market
DNA Vaccines Market: By Type (DNA vaccines for humans & DNA vaccines for animals), By Therapeutic Category (Oncology, Infectious Diseases, Neurology & Others) & By Region - Forecast(2018 - 2023)
Report Code : HCR 0280
Updated Date: 15 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. DNA Vaccines – Market Overview
2. Executive Summary
3. DNA Vaccines - Market Landscape 
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. DNA Vaccines - Market Forces
   4.1. Drivers
      4.1.1. Growing interest towards DNA vaccines as treatment option
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Force Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Customers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. DNA Vaccines Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. DNA Vaccines Market, By type
   6.1. DNA vaccines for humans
   6.2. DNA vaccines for animals
7. DNA Vaccines Market, By Geography
   7.1. Introduction
   7.2. North America
      7.2.1. US 
      7.2.2. Canada
      7.2.3. Mexico
   7.3. Europe
      7.3.1. U.K
      7.3.2. France
      7.3.3. Germany
      7.3.4. Italy
      7.3.5. Spain
      7.3.6. Rest of Europe
   7.4. Asia Pacific
      7.4.1. China
      7.4.2. South Korea
      7.4.3. Japan
      7.4.4. India
      7.4.5. Rest of Asia Pacific
   7.5. RoW
8. Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply - Contract
9. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   9.1. Inovio Biomedical Corp.
   9.2. Merck & Co.
   9.3. Mitsubishi Tanabe
   9.4. Dendreon Corporation
   9.5. ASTELLAS PHARMA
   9.6. Dynavax Technologies
   9.7. Sanofi
   9.8. Tekmira Pharmaceuticals
   9.9. GlaxoSmithKline Corp.
   9.10. Protein Sciences Corp.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Expert Insights
Vaccines are antigenic substances prepared from the causative agent of a disease or a synthetic substitute of it and generally used to impart immunity against one or several diseases. DNA vaccines are composed of deoxyribonucleic acid, which encodes antigens and stimulate a wider range of immune responses in the body with few side effects. DNA vaccines are a result of technological progression in biotechnology and gene delivery systems. Clinical trials of some DNA vaccines have shown promising results in treatment of several types of cancers like metastatic melanoma, prostate carcinoma, pancreatic cancer, and other solid tumors.

Factors driving global demand for DNA vaccine market are increasing awareness amongst health professional, fewer side effects, ease of development and lower cost, constant progress in biotechnology and conventional therapy failure in treatment of most infectious diseases.

This report provides information on DNA vaccine market size for the year 2014-2016, and forecast of the same for year 2021. It also focuses on market drivers, challenges, restraints, market dynamics, growth indicators, competitive landscape, potential growth opportunities and other key aspects with respect to DNA vaccine market.
 
DNA Vaccines Market

Globally, emerging technologies have taken healthcare closer to patients, DNA vaccines is one among these technology. They mainly use immunological pathways, which are difficult to achieve by other technologies. North America, Europe and other developed economies have good market for DNA vaccines due to their well-equipped healthcare infrastructure, a prominent research and development activities in the field of DNA vaccines, awareness among healthcare physicians on treatment options and percentage of people covered under healthcare insurance. APAC region has a growing demand for DNA vaccines due to increasing awareness on availability of new treatment options and increased focus on research and development activities.

This report identifies global DNA vaccine market based on different types and regional market as follows:
  • DNA vaccine market is segmented based on types. There are two main types’ human DNA vaccines and animals DNA vaccines, there are more than 100 products under clinical trial for different diseases in humans including HIV infection, cancer and infectious diseases etc. and three animal DNA vaccines are approved for veterinary use
  • This report is further segmented based on potential markets for DNA vaccines. A detailed analysis by region – United States, Europe, Asia-Pacific (APAC) and Rest of the World (RoW), has been provided in this report

This report looks into all the major companies operating in the DNA vaccines. Some of the major companies’ profiles are as follows:
  • Inovio Biomedical Corp.
  • Merck & Co.
  • Mitsubishi Tanabe
  • Dendreon Corporation
  • Astellas Pharma
List of Tables

Table 1: DNA Vaccines Market Overview 2017-2023
Table 2: DNA Vaccines Market Leader Analysis 2017-2018 (US$)
Table 3: DNA Vaccines Market Product Analysis 2017-2018 (US$)
Table 4: DNA Vaccines Market End User Analysis 2017-2018 (US$)
Table 5: DNA Vaccines Market Patent Analysis 2013-2018* (US$)
Table 6: DNA Vaccines Market Financial Analysis 2017-2018 (US$)
Table 7: DNA Vaccines Market Driver Analysis 2017-2018 (US$)
Table 8: DNA Vaccines Market Challenges Analysis 2017-2018 (US$)
Table 9: DNA Vaccines Market Constraint Analysis 2017-2018 (US$)
Table 10: DNA Vaccines Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: DNA Vaccines Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: DNA Vaccines Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: DNA Vaccines Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: DNA Vaccines Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: DNA Vaccines Market Value Chain Analysis 2017-2018 (US$)
Table 16: DNA Vaccines Market Pricing Analysis 2018-2023 (US$)
Table 17: DNA Vaccines Market Opportunities Analysis 2018-2023 (US$)
Table 18: DNA Vaccines Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: DNA Vaccines Market Supplier Analysis 2017-2018 (US$)
Table 20: DNA Vaccines Market Distributor Analysis 2017-2018 (US$)
Table 21: DNA Vaccines Market Trend Analysis 2017-2018 (US$)
Table 22: DNA Vaccines Market Size 2017 (US$)
Table 23: DNA Vaccines Market Forecast Analysis 2018-2023 (US$)
Table 24: DNA Vaccines Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: DNA Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 26: DNA Vaccines Market By Type, Revenue & Volume, By DNA vaccines for humans, 2018-2023 ($)
Table 27: DNA Vaccines Market By Type, Revenue & Volume, By DNA vaccines for animals, 2018-2023 ($)
Table 28: North America DNA Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 29: South america DNA Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 30: Europe DNA Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 31: APAC DNA Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 32: Middle East & Africa DNA Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 33: Russia DNA Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 34: Israel DNA Vaccines Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 35: Top Companies 2017 (US$)DNA Vaccines Market, Revenue & Volume
Table 36: Product Launch 2017-2018DNA Vaccines Market, Revenue & Volume
Table 37: Mergers & Acquistions 2017-2018DNA Vaccines Market, Revenue & Volume


List of Figures

Figure 1: Overview of DNA Vaccines Market 2017-2023
Figure 2: Market Share Analysis for DNA Vaccines Market 2017 (US$)
Figure 3: Product Comparison in DNA Vaccines Market 2017-2018 (US$)
Figure 4: End User Profile for DNA Vaccines Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in DNA Vaccines Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in DNA Vaccines Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in DNA Vaccines Market 2017-2018
Figure 8: Ecosystem Analysis in DNA Vaccines Market 2017
Figure 9: Average Selling Price in DNA Vaccines Market 2017-2023
Figure 10: Top Opportunites in DNA Vaccines Market 2017-2018
Figure 11: Market Life Cycle Analysis in DNA Vaccines Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy TypeDNA Vaccines Market Revenue, 2018-2023 ($)
Figure 13: Global DNA Vaccines Market - By Geography
Figure 14: Global DNA Vaccines Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 15: Global DNA Vaccines Market CAGR, By Geography, 2018-2023 (%)
Figure 16: North America DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 17: US DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 18: US GDP and Population, 2017-2018 ($)
Figure 19: US GDP – Composition of 2017, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2017-2018 ($)
Figure 21: Canada DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 22: Canada GDP and Population, 2017-2018 ($)
Figure 23: Canada GDP – Composition of 2017, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 25: Mexico DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 26: Mexico GDP and Population, 2017-2018 ($)
Figure 27: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 29: South America DNA Vaccines Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 30: Brazil DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 31: Brazil GDP and Population, 2017-2018 ($)
Figure 32: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 34: Venezuela DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 35: Venezuela GDP and Population, 2017-2018 ($)
Figure 36: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 38: Argentina DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 39: Argentina GDP and Population, 2017-2018 ($)
Figure 40: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 42: Ecuador DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 43: Ecuador GDP and Population, 2017-2018 ($)
Figure 44: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 46: Peru DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 47: Peru GDP and Population, 2017-2018 ($)
Figure 48: Peru GDP – Composition of 2017, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 50: Colombia DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 51: Colombia GDP and Population, 2017-2018 ($)
Figure 52: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 54: Costa Rica DNA Vaccines Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 55: Costa Rica GDP and Population, 2017-2018 ($)
Figure 56: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 58: Europe DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 59: U.K DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 60: U.K GDP and Population, 2017-2018 ($)
Figure 61: U.K GDP – Composition of 2017, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 63: Germany DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 64: Germany GDP and Population, 2017-2018 ($)
Figure 65: Germany GDP – Composition of 2017, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 67: Italy DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 68: Italy GDP and Population, 2017-2018 ($)
Figure 69: Italy GDP – Composition of 2017, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 71: France DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 72: France GDP and Population, 2017-2018 ($)
Figure 73: France GDP – Composition of 2017, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2017-2018 ($)
Figure 75: Netherlands DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 76: Netherlands GDP and Population, 2017-2018 ($)
Figure 77: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 79: Belgium DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 80: Belgium GDP and Population, 2017-2018 ($)
Figure 81: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 83: Spain DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 84: Spain GDP and Population, 2017-2018 ($)
Figure 85: Spain GDP – Composition of 2017, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 87: Denmark DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 88: Denmark GDP and Population, 2017-2018 ($)
Figure 89: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 91: APAC DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 92: China DNA Vaccines Market Value & Volume, 2018-2023
Figure 93: China GDP and Population, 2017-2018 ($)
Figure 94: China GDP – Composition of 2017, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2017-2018 ($)DNA Vaccines Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 96: Australia DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 97: Australia GDP and Population, 2017-2018 ($)
Figure 98: Australia GDP – Composition of 2017, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 100: South Korea DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 101: South Korea GDP and Population, 2017-2018 ($)
Figure 102: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 104: India DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 105: India GDP and Population, 2017-2018 ($)
Figure 106: India GDP – Composition of 2017, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2017-2018 ($)
Figure 108: Taiwan DNA Vaccines Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 109: Taiwan GDP and Population, 2017-2018 ($)
Figure 110: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 112: Malaysia DNA Vaccines Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 113: Malaysia GDP and Population, 2017-2018 ($)
Figure 114: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 116: Hong Kong DNA Vaccines Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 117: Hong Kong GDP and Population, 2017-2018 ($)
Figure 118: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 120: Middle East & Africa DNA Vaccines Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 121: Russia DNA Vaccines Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122: Russia GDP and Population, 2017-2018 ($)
Figure 123: Russia GDP – Composition of 2017, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 125: Israel DNA Vaccines Market Value & Volume, 2018-2023 ($)
Figure 126: Israel GDP and Population, 2017-2018 ($)
Figure 127: Israel GDP – Composition of 2017, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 129: Entropy Share, By Strategies, 2017-2018* (%)DNA Vaccines Market
Figure 130: Developments, 2017-2018*DNA Vaccines Market
Figure 131: Company 1 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 132: Company 1 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 133: Company 1 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 134: Company 2 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 135: Company 2 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 136: Company 2 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 137: Company 3 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 138: Company 3 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 139: Company 3 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 140: Company 4 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 141: Company 4 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 142: Company 4 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 143: Company 5 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 144: Company 5 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 145: Company 5 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 146: Company 6 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 147: Company 6 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 148: Company 6 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 149: Company 7 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 150: Company 7 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 151: Company 7 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 152: Company 8 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 153: Company 8 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 154: Company 8 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 155: Company 9 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 156: Company 9 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 157: Company 9 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 158: Company 10 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 159: Company 10 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 160: Company 10 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 161: Company 11 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 162: Company 11 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 163: Company 11 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 164: Company 12 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 165: Company 12 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 166: Company 12 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 167: Company 13 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 168: Company 13 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 169: Company 13 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 170: Company 14 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 171: Company 14 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 172: Company 14 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Figure 173: Company 15 DNA Vaccines Market Net Revenue, By Years, 2017-2018* ($)
Figure 174: Company 15 DNA Vaccines Market Net Revenue Share, By Business segments, 2017 (%)
Figure 175: Company 15 DNA Vaccines Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll